Dr Samantha Philip and Dr Kathryn E Kyler discuss the impact of weight bias in healthcare and ways for physicians to be more ...

Orfoglipron was associated with improved glycemic control and weight reduction among patients with early-stage type 2 ...

Oral semaglutide was associated with more pronounced cardiovascular benefits among patients with higher baseline HbA1c in ...

The FDA has approved a labeling update for Leqvio (inclisiran) allowing for first-line use in the treatment of hypercholesterolemia.

Baseline HbA1c was associated with odds of insulin dependent 1 year after patients underwent total pancreatectomy with islet autotransplantation.

Among patients with chronic hepatitis C virus (HCV), post-sustained virologic response (SVR) hepatocellular carcinoma (HCC) risk is significantly higher with metabolic dysfunction-associated steatotic ...

The recombinant zoster vaccine significantly lowers the risk for shingles complications among individuals with IBD.

New opioid labeling requirements will better highlight the risks of long-term use, including misuse, addiction, and overdose.

The Bill and Melinda Gates Foundation will invest $2.5 billion in research on gynecological health, obstetrics, and contraceptive innovation.

The USPSTF recommends screening adults unhealthy alcohol use in primary care settings and providing brief behavioral counseling interventions.

Individuals who tested positive after a fecal immunochemical test developed postcolonoscopy CRC within 3 years.

SURPASS-CVOT evaluated the efficacy and safety of tirzepatide compared with dulaglutide in adults with T2D and a confirmed ASCVD.